Related Experiment Video
Updated: Oct 30, 2025
08:02
In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
Published on: January 22, 2020
5.6K
Astaxanthin Protects Dendritic Cells from Lipopolysaccharide-Induced Immune Dysfunction
Yinyan Yin1,2, Nuo Xu1, Yi Shi1
1College of Medicine, Yangzhou University, Yangzhou 225009, China.
Marine Drugs
|July 2, 2021
Summary
Astaxanthin, a natural pigment, was found to regulate dendritic cells (DCs) and reduce inflammation, offering a potential new treatment for sepsis by improving survival rates in mice.
Area of Science:
- Immunology
- Pharmacology
- Biochemistry
Background:
- Astaxanthin is a red carotenoid pigment from seafood with known antioxidant properties.
- Its anti-inflammatory effects, particularly on dendritic cells (DCs) for sepsis therapy, are not well understood.
- Dendritic cells play a crucial role in immune regulation and are implicated in sepsis pathogenesis.
Purpose of the Study:
- To investigate the effects of astaxanthin on the immune functions of murine dendritic cells.
- To determine if astaxanthin can modulate DC responses in the context of lipopolysaccharide (LPS)-induced inflammation.
- To explore the potential of astaxanthin as a therapeutic agent for sepsis by targeting DC immune dysfunction.
Main Methods:
- Murine dendritic cells were treated with astaxanthin and lipopolysaccharide (LPS).
- Expression of inflammatory cytokines and DC surface markers was analyzed.
- Endocytosis, migration (CCR7 expression), and T cell proliferation were assessed.
- The role of the HO-1/Nrf2 pathway was investigated.
- In vivo studies involved oral administration of astaxanthin to LPS-challenged mice.
Main Results:
- Astaxanthin significantly reduced LPS-induced expression of inflammatory cytokines (TNF-α, IL-6, IL-10) and DC phenotypic markers (MHCII, CD40, CD80, CD86).
- It enhanced DC endocytosis and inhibited LPS-induced DC migration by downregulating CCR7, subsequently reducing allogeneic T cell proliferation.
- Astaxanthin activated the HO-1/Nrf2 axis, mitigating LPS-induced DC immune dysfunction.
- Oral administration of astaxanthin markedly improved the survival rate of LPS-challenged mice.
Conclusions:
- Astaxanthin effectively modulates dendritic cell immune functions, suppressing inflammatory responses and migration.
- The anti-inflammatory effects of astaxanthin involve the activation of the HO-1/Nrf2 pathway.
- Astaxanthin demonstrates therapeutic potential for sepsis treatment by preventing DC immune dysfunction and enhancing survival.
